Pharmaceutical dosage forms and compositions of 5-ht1a...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 405/12 (2006.01) A61K 31/496 (2006.01) A61P 25/00 (2006.01) C07D 213/75 (2006.01)

Patent

CA 2560243

This invention relates to, for example, novel formulations and methods for the delivery of 4-~cyano-N- {(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5 yl)- piperazin-l-yl]-propyl}-N-pyridin-2-yl~benzamide, pharmaceutically acceptable salts thereof, structurally related compounds and/or metabolites; as well as to use of these formulations and methods for treating disease.

L'invention concerne, par exemple, de nouvelles formulations et méthodes destinées à l'administration de 4-cyano-N- {(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5 yl)-piperazin-l-yl]-propyl}-N-pyridin-2-yl-benzamide, des sels pharmaceutiquement acceptables desdites formulations, des composés et/ou des métabolites présentant des relations structurelles. L'invention concerne également l'utilisation de ces formulations et de ces méthodes dans le traitement de maladies.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical dosage forms and compositions of 5-ht1a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical dosage forms and compositions of 5-ht1a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical dosage forms and compositions of 5-ht1a... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1753453

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.